Top 5 global vaccine products based on revenue in 2017 and 2024 (in million U.S. dollars)

Leading five global vaccine products by revenue 2017 and 2024 This statistic displays the top 5 global vaccine products based on their revenues worldwide in 2017, and a projection for 2024. Pfizer's pneumococcal vaccine, Prevnar 13, is expected to generate some 5.76 billion U.S. dollars in revenues by 2024. A vaccine often contains an agent that is made from a weakened form of a disease microbe, that is then used to stimulate the body's immune system to destroy and recognize the microorganism in case of later exposures.
Top vaccine products

Vaccines act as a preventive measure to improve immunity to certain diseases. Often, vaccines are created from a weakened or killed form of a microbe which allows the immune system to react and create a record of it, so that in the future, it can easily recognize these microorganisms. Vaccine use can easily help to prevent contraction of certain viruses such as influenza. However, some countries may not have easy access to vaccinations. In India, there were approximately 1.8 million deaths due to vaccine-preventable diseases as of 2013.

The global vaccination market generated 27.7 billion U.S. dollars in 2017 and is projected to total around 45 billion U.S. dollars in 2024. As of 2014, there were 18 new vaccines that were moving along the research and development pipeline for neglected diseases. Vaccines in the United States accumulated some of the world’s largest revenues, totaling 10.8 billion U.S. dollars in 2013. In comparison, Germany generated around three billion U.S. dollars at the vaccine market. Prevnar 13 and Gardasil are the top vaccines in the world, generating 5.7 billion and 2.4 billion U.S. dollars, respectively, in 2017. Prevnar 13 is marketed by Pfizer and Daewoong.
Show more
Loading statistic...
20172024*
Prevnar 13 (Pfizer + Daewoong)5,6935,756
Gardasil (Merck & Co)2,3803,279
Pentacel (Sanofi)2,0652,904
Fluzone (Sanofi)1,7982,406
Combination Respiratory Vaccine (Novavax)-1,821
20172024*
Prevnar 13 (Pfizer + Daewoong)5,6935,756
Gardasil (Merck & Co)2,3803,279
Pentacel (Sanofi)2,0652,904
Fluzone (Sanofi)1,7982,406
Combination Respiratory Vaccine (Novavax)-1,821
Download Settings Share
Chart type
Datalabels
Share on Social Media
HTML code to embed chart as PNG (FAQ)
Download started
Please be patient - this may take a moment
Description Source More information
This statistic displays the top 5 global vaccine products based on their revenues worldwide in 2017, and a projection for 2024. Pfizer's pneumococcal vaccine, Prevnar 13, is expected to generate some 5.76 billion U.S. dollars in revenues by 2024. A vaccine often contains an agent that is made from a weakened form of a disease microbe, that is then used to stimulate the body's immune system to destroy and recognize the microorganism in case of later exposures.
Top vaccine products

Vaccines act as a preventive measure to improve immunity to certain diseases. Often, vaccines are created from a weakened or killed form of a microbe which allows the immune system to react and create a record of it, so that in the future, it can easily recognize these microorganisms. Vaccine use can easily help to prevent contraction of certain viruses such as influenza. However, some countries may not have easy access to vaccinations. In India, there were approximately 1.8 million deaths due to vaccine-preventable diseases as of 2013.

The global vaccination market generated 27.7 billion U.S. dollars in 2017 and is projected to total around 45 billion U.S. dollars in 2024. As of 2014, there were 18 new vaccines that were moving along the research and development pipeline for neglected diseases. Vaccines in the United States accumulated some of the world’s largest revenues, totaling 10.8 billion U.S. dollars in 2013. In comparison, Germany generated around three billion U.S. dollars at the vaccine market. Prevnar 13 and Gardasil are the top vaccines in the world, generating 5.7 billion and 2.4 billion U.S. dollars, respectively, in 2017. Prevnar 13 is marketed by Pfizer and Daewoong.
Show more
Release date
June 2018
Region
Worldwide
Survey time period
as of May 2018
Supplementary notes
Statistic is ranked by 2024 revenue.
* Projected.
Open this statistic in...

More information

Statista Accounts: Access All Statistics. Starting from $588 / Year

Basic Account

Get to know the platform

You only have access to basic statistics.

Register for free

Premium Account

Your perfect start with Statista

  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references

$49 / Month *

Corporate Account

Full access

Corporate solution including all features.

Send request

* All products require an annual contract.
   Prices do not include sales tax
   (New York residents only).
Leading companies trust Statista:

Related Studies: Available to Download in PDF or PPTX Format

Top pharmaceutical drugs

All Information
in one Presentation

Top pharmaceutical drugs

Everything On "Top pharmaceutical drugs" in One Document: Edited and Divided into Handy Chapters. Including Detailed References.

Other Reports & Dossiers
I think of Statista as Google for researchers. Statista provides you with the information you search for right away.
Dr. Horst Stipp

Dr. Horst Stipp
EVP, Research & Innovation, Advertising Research Foundation

Statistics on "Vaccinations in the U.S."

  • Global overview
The most important statistics
  • U.S. vaccination impact
  • Children and adolescents
The most important statistics
  • Adults
The most important statistics
  • Injury and death from vaccines
The most important statistics
  • Public opinion
  • Focus: Human papillomavirus (HPV)
Need help with using Statista for your research? Tutorials and first steps

Further Content: Statistics, Studies, and Topic Pages

Statistics on the topic

Topics

About Statista

Learn more about how Statista can support your business.

Request webinar
Do you have any questions about our business solutions?

We provide you with detailed information about our Corporate Account.

5 News

We use cookies to personalize contents and ads, offer social media features, and analyze access to our website. In your browser settings you can configure or disable this, respectively, and can delete any already placed cookies. For details, please see your browser’s Help section (by pressing F1). Please see our privacy statement for details about how we use data.